Vinicius Ernani

Vinicius Ernani practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Vinicius Ernani's NPI, 1437460532, was assigned on June 23, 2010. Vinicius Ernani graduated from Pontifical Catholic University of Rio Grande do Sul in 2008. Vinicius Ernani holds Arizona license 61504.

Vinicius Ernani's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Vinicius Ernani's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Vinicius Ernani is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Vinicius Ernani's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Vinicius Ernani practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Vinicius Ernani's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Vinicius Ernani is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Vinicius Ernani's licenses on file in 3 states: Arizona, Florida and Nebraska.

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, lung cancer and lymphoma among the conditions Vinicius Ernani treats.

CMS data shows 94,890 Medicare services from Vinicius Ernani across 63 procedure codes in 2024, for 1,036 Medicare patients. Medicare paid $2,049,069 for them. Every service was in an office.

CMS counts 1,036 Medicare patients who saw Vinicius Ernani in 2024. The largest group is 65 to 74, with 475 patients. 73% of them have high cholesterol, and 70% have high blood pressure. 3% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Vinicius Ernani's median patient age at 73, with 56% women.

In 2024, Vinicius Ernani wrote 574 Medicare Part D claims for 130 patients. 62% of them were for generic drugs. CMS names the drug for 427 of them, across 10 drugs with 11 or more claims each, at $1,975,138 in total drug cost. In 2023, CMS named 327 claims across 11 drugs.

Vinicius Ernani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Vinicius Ernani as offering telehealth.

Dmand AI links 47 papers to Vinicius Ernani, published from 2011 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Small Cell Lung Carcinoma. Vinicius Ernani has published most often in Cancer Treat Res Commun. Vinicius Ernani's most frequent co-authors are Nathan Yung-Chuen Yu, MD, Jonathan D'Cunha, MD, PhD and Konstantinos Leventakos, MD.

Dmand AI links Vinicius Ernani to 6 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung and Brain Neoplasms.

CMS Open Payments shows 88 general payments to Vinicius Ernani from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. AstraZeneca Pharmaceuticals LP paid the most, $22,653.

Vinicius Ernani graduated from Pontifical Catholic University of Rio Grande do Sul in 2008.

Vinicius Ernani is in network with 6 carriers, including United Healthcare, Aetna and Blue Cross and Blue Shield of Kansas City. PPO plans come from the most carriers, 3. Check the plan with the practice before a visit.